Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-21

Clinical Trial Update: Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 trial investigating Staphylococcus aureus and skin microbiome dynamics during flare and resolution in atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Jacob Pontoppidan Thyssen | Conditions: Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 4 | Status: UNKNOWN